Ethos Technologies (LIFE) Research & Development (2025 - 2026)
Ethos Technologies (LIFE) posted Research & Development of $128.1 million for Q2 2026, down 11.12% on a QoQ basis from $144.1 million in Q1 2026, and up 147.52% year-over-year from $51.7 million in Q2 2025.
Powered by 
Analysis
Ethos Technologies (LIFE) Research & Development (2025 - 2026) Analysis & Trends
Ethos Technologies has reported Research & Development for 2 years, with the latest figure at $128.1 million in Q2 2026.
- On a quarterly basis, Research & Development rose 147.52% year-over-year to $128.1 million in Q2 2026; TTM through Jun 2026 was $380.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $229.3 million, up 54.25% from the prior year.
- Research & Development was $128.1 million for Q2 2026 at Ethos Technologies, down from $144.1 million in the prior quarter.
- The five-year high for Research & Development was $144.1 million in Q1 2026, with the low at $51.7 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Hinge Health | 7.08 Bn | 6.69 Bn | 183.95 Mn | 81.41 Mn |
| 2 | Hims & Hers Health | 6.42 Bn | 5.57 Bn | 480.80 Mn | 54.90 Mn |
| 3 | Ethos Technologies | 2.47 Bn | 2.30 Bn | 185.54 Mn | 128.09 Mn |
| 4 | Omada Health | 1.33 Bn | 1.11 Bn | 63.79 Mn | 29.89 Mn |
| 5 | Teladoc Health | 1.11 Bn | 337.15 Mn | 416.09 Mn | 62.86 Mn |
| 6 | Talkspace | 870.58 Mn | 779.48 Mn | 24.80 Mn | 14.66 Mn |
| 7 | Akso Health | 228.22 Mn | 228.05 Mn | - | - |
| 8 | LifeMD | 141.94 Mn | 141.94 Mn | - | - |
| 9 | eHealth | 29.34 Mn | -71.71 Mn | - | 11.30 Mn |
| 10 | Mangoceuticals | 6.95 Mn | 6.70 Mn | 44,215.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 128.09 Mn |
| Mar 31, 2026 | 144.11 Mn |
| Jun 30, 2025 | 51.75 Mn |
| Mar 31, 2025 | 56.38 Mn |